NCT00356798View on ClinicalTrials.gov

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

April 30, 2006

Conditions

Influenza

Interventions

BIOLOGICAL

an inactivated whole virion H5N1 vaccine, adjuvanted

Trial Locations (1)

100029

China-Japan Friendship Hospital, Beijing

All Listed Sponsors

collaborator

Ministry of Science and Technology of the People´s Republic of China

OTHER_GOV

lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT00356798 - Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects | Biotech Hunter | Biotech Hunter